NR565 / NR 565: Advanced Pharmacology Fundamentals Final Review – Week 5 . (Graded A) Chamberlain College of Nursing

Document Content and Description Below

NR-565 Advanced Pharmacology Fundamentals NR565 Final Review – Week 5 1. Bacteriostatic - Bacteriostatic drugs focus largely on killing the bacteria that is causing illness and less on in... hibiting the growth of the bacteria. Ex: clindamycin, macrolides, sulfonamides and tetracyclines 2. Bactericidal - 3. Drug resistance - 4. Drug names: Penicillin - 5. Aminopenicillins - 6. Penicillinase-Resistant Penicillin’s - 7. Anti-Pseudomonal Penicillin’s - 8. Beta-Lactams - 9. First-line therapy for acute otitis media (AOM) and sinusitis - 10. Recommended to treat streptococcal pharyngitis - 11. First-line therapy for infection following bites, including human. - 12. Natural PCNs treat... - 13. Aminopenicillins - 14. PCN ADRs - 15. PCN- testing for prolonged therapy - 16. PCN Patient education - 17. 1st generation cephalosporins - 18. 2nd generation cephalosporins - 19. Cephalosporin increased activity against H. Influenza - 20. 3rd generation cephalosporins - 21. 3rd generation cephalosporins treat... - 22. 4th generation cephalosporin - 23. 4th generation cephalosporins treat... - 24. 2nd generation cephalosporins treat - 25. Cephalosporin Pharmacokinetics - 26. Cephalosporin ADRs - 27. 1st generation cephalosporins treat... - 28. second- line drug for UTI - 29. used for general condition gonococcus (GC)/chlamydia - 30. Cephalosporin used for CAP - 31. Monitoring for cephalosporins - 32. Education for cephalosporins - 33. Fluoroquinolones are used to treat - 34. Fluoroquinolones - 35. Fluoroquinolones Pharmacokinetics - 36. Fluoroquinolones black box warning - 37. Fluoroquinolone ADRs - 38. Avoid floroquinolones in... - 39. Fluoroquinolone monitoring - 40. Fluoroquinolone Pt education - 41. Lincosamides - 42. Clindamycin decreased in use with - 43. Clindamycin Susceptible organisms - 44. Treat infections secondary to staphylococcal or streptococcal species in penicillin-allergic patients with - 45. Clindamycin Absorption/Distribution - 46. clindamycin precautions - 47. Do not use macrolides for... - 48. Drug of Choice (DOC) for mycoplasma community-acquired pneumonia - 49. Macrolides and CYP - 50. macrolide adrs - 51. macrolide monitoring - 52. macrolide pt education - 53. MACROLIDES, AZALIDES, KETOLIDES - 54. MACROLIDES, AZALIDES, KETOLIDES treat... - 55. Sulfasalazine (Azulfidine) is used in the treatment of - 56. Mafenide (Sulfamylon) and silver sulfadiazine (Silvadene) are used - 57. Special uses for sulfonamides - 58. Azithromycin with or without food - 59. SULFONAMIDES, TRIMETHOPRIM & NITROFURANTOIN ADRs - 60. SULFONAMIDES, TRIMETHOPRIM & NITROFURANTOIN clinical use - 61. SULFONAMIDES, TRIMETHOPRIM & NITROFURANTOIN monitoring - 62. SULFONAMIDES, TRIMETHOPRIM & NITROFURANTOIN education - 63. Vancomycin used for - 64. glycopeptides- names - 65. DALBAVANCIN - 66. oral vanco should not be used for - 67. vancomycin should be used with caution in - 68. red man’s syndrome - 69. Treat C. Diff with - 70. vanco ADRs - 71. Treatment of CDI - 72. Treatment of Group A and Group B beta streptococci - 73. Cross sensitivity with cephalosporins - 74. Contraindications for topical beta blockers - 75. Prophylaxis for ophthalmia neonatorum - 76. antiglaucoma agents - 77. Conjunctivitis treatment - 78. Cerumenosis - 79. Cerumenosis treatment - 80. UTI first line abx treatment - 81. Simple, uncomplicated upper UTI treatment - 82. Simple, uncomplicated lower UTI treatment - 83. UTI treatment risk for STD - 84. UTI treatment in pregnancy - 85. UTI treatment afebrile children >1mo - 86. UTI treatment in febrile children >1mo - 87. most common lower uti organisms - 88. most common upper uti organisms - 89. Recurrent UTI prevention - 90. risk factors for UTI - 91. indications for referral to urologist - 92. Complicating factors in utis [Show More]

Last updated: 1 year ago

Preview 1 out of 16 pages